A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer

NYU Langone Health, New York

Icahn School of Medicine at Mount Sinai, New York

UPMC Hillman Cancer Center, Pittsburgh

Hospital of the Univ of Pennsylvania Perlman Center, Philadelphia

Sibley Memorial Hospital, Washington D.C.

Virginia Cancer Specialists, PC, Fairfax

Medical University of South Carolina, Charleston

Sarah Cannon Research Institute, Nashville

University of Louisville Brown Cancer Center, Louisville

University of Kentucky Medical Center, Lexington

TriHealth Cancer Institute; Good Samaritan Hospital, Cincinnati

Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit

University of Wisconsin Clinical Science Center, Madison

Avera Cancer Institute, Sioux Falls

Washington University School of Medicine, Center for Adv Medicine, St Louis

University of Kansas Cancer Center - Westwood, Westwood

Nebraska Cancer Specialists - Legacy, Omaha

University of Texas Southwestern Medical Center, Dallas

Comprehensive Cancer Centers of Nevada - Southern Hills, Las Vegas

Cancer and Blood Speciality Clinic, Long Beach

Sharp Memorial Hospital (Oncology Clinical Research), San Diego

Providence Cancer Institute Franz Clinic, Portland

Atlantic Health System / Morristown Medical Center, Morristown